11:32 AM EST, 11/06/2025 (MT Newswires) -- Genmab ( GMAB ) reported a Q3 net profit Thursday of $6.46 per diluted share, up from $2.92 a year earlier.

Analysts polled by FactSet expected $4.86.

Revenue for the quarter ended Sept. 30 was $1.02 billion, compared with $816 million a year earlier.

Analysts polled by FactSet expected $990.4 million.

The company reiterated its 2025 revenue guidance of $3.5 billion to $3.7 billion. Analysts polled by FactSet expect $3.67 billion.

Genmab ( GMAB ) shares were down more than 2% in recent Thursday trading.

Price: 28.46, Change: -0.74, Percent Change: -2.52